We are live on ! Find out more
FBRX icon

Forte Biosciences
FBRX

32 hedge funds and large institutions have $13.3M invested in Forte Biosciences in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.02% more ownership

Funds ownership: 2.08% → 2.09% (+0.02%)

6% less funds holding

Funds holding: 34 → 32 (-2)

14% less capital invested

Capital invested by funds: $15.5M → $13.3M (-$2.22M)

17% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 6

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

Holders
32
Holders Change
-2
Holders Change %
-5.88%
% of All Funds
0.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
6
Closed
4
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
-$24K

Top Buyers

Rank Fund Capital Flow
1
ACM
ADAR1 Capital Management
Texas
+$119K
2
Citadel Advisors
Citadel Advisors
Florida
+$13.7K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$4.76K
4
TRCT
Tower Research Capital (TRC)
New York
+$4.1K
5
Renaissance Technologies
Renaissance Technologies
New York
+$1.6K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$5.22K
2
TSS
Two Sigma Securities
New York
-$3K
3
CG
Cutler Group
California
-$3K
4
LA
LM Advisors
California
-$2.08K
5
Group One Trading
Group One Trading
Illinois
-$907
Name Holding Trade Value Shares
Change 		Change in
Stake
TCM
1
Tybourne Capital Management
Hong Kong
$2.52M – – –
PA
2
Perceptive Advisors
New York
$2.27M – – –
BI
3
BVF Inc
California
$2.09M – – –
CCC
4
Cable Car Capital
California
$1.41M – – –
FAM
5
Fred Alger Management
New York
$1.28M – – –
FCM
6
Farallon Capital Management
California
$1.27M – – –
BCM
7
BML Capital Management
Indiana
$1.23M – – –
Vanguard Group
8
Vanguard Group
Pennsylvania
$463K – – –
Geode Capital Management
9
Geode Capital Management
Massachusetts
$241K +$4.76K +273 +2%
BlackRock
10
BlackRock
New York
$122K -$5.22K -299 -4%
ACM
11
ADAR1 Capital Management
Texas
$119K +$119K +6,820 New
Renaissance Technologies
12
Renaissance Technologies
New York
$92K +$1.6K +92 +2%
State Street
13
State Street
Massachusetts
$29.2K – – –
Two Sigma Investments
14
Two Sigma Investments
New York
$28.4K -$70 -4 -0.2%
Citadel Advisors
15
Citadel Advisors
Florida
$19.8K +$13.7K +784 +227%
Northern Trust
16
Northern Trust
Illinois
$18.7K – – –
Two Sigma Advisers
17
Two Sigma Advisers
New York
$17.3K – – –
Goldman Sachs
18
Goldman Sachs
New York
$14.5K +$17 +1 +0.1%
Group One Trading
19
Group One Trading
Illinois
$10.2K -$907 -52 -8%
AWM
20
Aries Wealth Management
Maine
$9.05K – – –
TRCT
21
Tower Research Capital (TRC)
New York
$8.1K +$4.1K +235 +102%
TSS
22
Two Sigma Securities
New York
$7.74K -$3K -172 -28%
HSBC Holdings
23
HSBC Holdings
United Kingdom
$7.53K – – –
Osaic Holdings
24
Osaic Holdings
Arizona
$754 – – –
Morgan Stanley
25
Morgan Stanley
New York
$692 -$698 -40 -50%
1
2

FBRX Hedge Fund Activity: Q1 2024 in Review

32 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Forte Biosciences (FBRX) for Q1 2024, worth a combined $13.3M — down 14% from $15.5M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of FBRX and 2 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 5 added.

The largest buyer was ADAR1 Capital Management, opening a new position worth an estimated $119K. The largest seller was BlackRock, cutting an estimated $5.22K.

  • 32 institutional investors held Forte Biosciences (FBRX) as of Q1 2024, down from 34 in Q4 2023.
  • Funds reported $13.3M of Forte Biosciences stock for Q1 2024, down 14% quarter-over-quarter.
  • 2 funds opened new Forte Biosciences positions in Q1 2024 and 4 closed out, a net change of -2 holders.
  • The largest Forte Biosciences buyer in Q1 2024 was ADAR1 Capital Management, an estimated $119K added.
  • The largest Forte Biosciences seller in Q1 2024 was BlackRock, an estimated $5.22K sold.

Based on aggregated 13F filings for Q1 2024.